Related Experiment Videos
Efficient expression of foreign genes in human CD34(+) hematopoietic precursor cells using electroporation
M H Wu1, D N Liebowitz, S L Smith
1Section of Hematology-Oncology and Cancer Research Center, Department of Medicine, University of Chicago, 5841 S Maryland Avenue, Box MC2115, Chicago, IL 60637, USA.
Gene Therapy
|April 21, 2001
Summary
Electroporation effectively introduces foreign genes into human CD34(+) hematopoietic precursor cells, enhancing their potential for gene therapy. This method stably integrates genes into primitive stem cells, offering new treatment possibilities.
Area of Science:
- Hematology
- Molecular Biology
- Gene Therapy
Background:
- Human CD34(+) hematopoietic precursor cells are crucial for treating genetic disorders and protecting against chemotherapy.
- Electroporation offers a non-viral, non-chemical method for gene delivery into mammalian cells, primarily used for rapidly dividing cells.
Purpose of the Study:
- To optimize electroporation conditions for efficient gene delivery into human CD34(+) hematopoietic precursor cells.
- To assess the transient and stable gene expression in these cells and their progenitor colonies.
Main Methods:
- Human CD34(+) cells were cultured and stimulated to increase cell cycle progression.
- Optimal electroporation parameters (voltage, duration, DNA concentration, cell density) were determined using enhanced green fluorescent protein (EGFP) as a reporter.
- Gene expression, integration, and colony-forming capacity of electroporated cells were analyzed using flow cytometry, methylcellulose assays, and inverse PCR.
Main Results:
- Optimal electroporation yielded transient EGFP expression in 21% of CD34(+) cells, including primitive subsets.
- Electroporation resulted in 20% EGFP-expressing colonies (CFU-GM, BFU-E, CFU-mix) and 22% EGFP-expressing long-term colony-initiating cells (LTC-IC).
- Reporter gene integration into LTC-IC genomic DNA was confirmed via inverse PCR and DNA sequencing.
Conclusions:
- Electroporation is a viable method for delivering exogenous genes into human hematopoietic precursor cells.
- The technique allows for stable gene integration into primitive stem cell populations, supporting potential therapeutic applications.